Literature DB >> 7526790

HPV replication in experimental models: effects of interferon.

J D Gangemi1, L Pirisi, M Angell, J W Kreider.   

Abstract

Preclinical evaluation of the effectiveness of interferon (IFN) therapy on human papillomaviruses (HPV) has been hampered by the inability to propagate these viruses in cell culture. Nonetheless, interferon is used extensively in the treatment of HPV infections. Alpha interferons in particular have found a place in the treatment of anogenital disease, plantar warts, and laryngeal papillomas. While their is significant clinical evidence to suggest that interferon is useful in therapy of disease, the cellular mechanism(s) (i.e., antiviral, antiproliferative, immunomodulatory) by which IFN is able to control HPV-induced pathology is not well understood. This review focuses on experimental animal and cell culture models which are currently being used to help identify the antiviral, antiproliferative and immunomodulatory effects of IFN on HPV infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526790     DOI: 10.1016/0166-3542(94)90066-3

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  7 in total

1.  Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum.

Authors:  J Monsonego; G Cessot; S E Ince; A R Galazka; A K Abdul-Ahad
Journal:  Genitourin Med       Date:  1996-04

2.  Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells.

Authors:  Anastasia Bachmann; Brigitte Hanke; Rainer Zawatzky; Ubaldo Soto; Jan van Riggelen; Harald zur Hausen; Frank Rösl
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.

Authors:  S Parangi; M O'Reilly; G Christofori; L Holmgren; J Grosfeld; J Folkman; D Hanahan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

Review 4.  Topical imiquimod: a review of its use in genital warts.

Authors:  C M Perry; H M Lamb
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

5.  Ocular surface tumors.

Authors:  Ihab Saad Othman
Journal:  Oman J Ophthalmol       Date:  2009-01

6.  Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.

Authors:  Swathi Kaliki; Swati Singh; Sadiya Iram; Dharani Tripuraneni
Journal:  Indian J Ophthalmol       Date:  2016-10       Impact factor: 1.848

7.  Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia.

Authors:  Reza Ghaffari; Sahar Barijani; Arash Alivand; Golshan Latifi; Hamed Ghassemi; Mehran Zarei-Ghanavati; Ali R Djalilian
Journal:  J Curr Ophthalmol       Date:  2021-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.